A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.
NCT00378183
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizoaffective Disorder
Schizophrenia
Interventions
DRUG:
risperidone
Sponsor
Janssen, LP